Medicine and Dentistry
Nonalcoholic Fatty Liver
90%
Liver Cirrhosis
34%
Liver Disease
23%
Ammonium
22%
Hepatic Encephalopathy
22%
Urea Cycle
19%
Brain Disease
14%
Galactose
14%
Liver Function
12%
Steatosis
12%
Acute on Chronic Liver Failure
11%
Insulin Resistance
11%
Fibrosis
11%
Disease
11%
Cognitive Defect
10%
Adolescent
9%
Encephalitis
9%
Hyperammonemia
8%
Bariatric Surgery
7%
Pathophysiology
7%
Liver Transplantation
7%
Chronic Liver Disease
6%
Disease Severity
5%
Supplementation
5%
Portal Hypertension
5%
Neuroinflammation
5%
Endotoxin
5%
Macrophage Activation
5%
Cardiovascular Risk
5%
Brain Hypoxia
5%
Macrophage
5%
Placebo
5%
Transcriptome
5%
Outpatient
5%
Alcohol Liver Disease
5%
Systematic Review
5%
Positron Emission Tomography
5%
Drug Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Liver Cirrhosis
25%
Hepatic Encephalopathy
25%
Inflammation
23%
Liver Disease
19%
Fibrosis
19%
Ammonium
19%
Galactose
16%
Alcohol Liver Disease
15%
Lipopolysaccharide
14%
Steatosis
13%
Cognitive Defect
12%
Endotoxin
10%
Disease
10%
Acute on Chronic Liver Failure
9%
Interferon
9%
Encephalitis
9%
Fatty Liver
7%
Hyperammonemia
7%
Portal Hypertension
6%
Hypercholesterolemia
5%
Nervous System Inflammation
5%
Brain Hypoxia
5%
Cardiovascular Risk
5%
Antioxidant
5%
Immunology and Microbiology
Non-Alcoholic Fatty Liver Disease
46%
Urea Cycle
43%
Steatohepatitis
35%
Prednisolone
16%
Liver Function
15%
Inflammatory Bowel Disease
14%
Blood Plasma
12%
Systemic Inflammation
11%
Macrophage Activation
10%
Infliximab
9%
Brain Blood Flow
9%
CD163
9%
Somatomedin C
8%
Homeostasis
7%
Normal Human
6%
Interleukin 6
6%
Macrophage
6%
Liver Transplantation
5%
Neutrophil
5%
